Romanillos, Jaymar H.

HRN: 09-12-23  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/09/2022
09/16/2022
IV
570mg
Q6hours
PCAP-C With Moderate Dehydration
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: